fda removes semaglutide from drug shortage list february 21 2025 Ozempic and Wegovy removed the FDA's Navigating changes in access to

A 2023 review of GLP-1 users found that probiotic supplementation did not significantly accelerate weight loss beyond medication alone, though participants with pre-existing dysbiosis (bacterial imbalance) showed slightly better metabolic markers

How Your Genetics Relate to GLP-1 Pathways PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month of treatment) analyzes variants in genes controlling vascular integrity, inflammation response, and bleeding tendency

Promoting Healthy Nerve Function Healthy nerve function is key to optimal physical performance

Secondary analyses from the SURPASS programme suggest effects on cardiovascular risk markers, including blood pressure and lipid profiles, though these findings should be considered exploratory